- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01131598
Acute Lung Injury in Children: Epidemiology and Natural History. PEDIATRIC ALIEN. (ALIEN)
Acute Lung Injury in Spanish Children
Studieoversikt
Status
Detaljert beskrivelse
Acute lung injury (ALI) is a clinical syndrome of rapid onset of non-cardiogenic pulmonary edema manifested clinically by hypoxemia (PaO2/FiO2≤300 mmHg) and bilateral pulmonary infiltrates. When the hypoxemia is severe (PaO2/FiO2≤200 mmHg) it is termed the acute respiratory distress syndrome (ARDS). It represents a significant public health issue. Patients with ALI or ARDS require admission into critical care units for advanced life support and utilize considerable health care resources.
An immense plethora of translational knowledge has been acquired since the first description of ARDS in 1967. At the present, estimates of the incidence of ARDS and ALI in children are unknown. In adults, the estimates of ALI/ARDS incidence have varied widely, and the true magnitude of this health problem still remains unclear. Current estimates of the incidence of adult ALI/ARDS range from 15 to 80 cases per 100.000 population, or almost 40.000 cases per year in Spain. Combined mortality rates for adult ALI/ARDS range between 30-45% but it is not clear whether this figures can be translated in the pediatric population. ALI and ARDS occur as a complication or as the primary cause of critical illness in patients, usually after severe infection or trauma.
Published epidemiological studies on ALI and ARDS in the last 20 years are difficult to compare. Some reports have used different definitions for ALI and ARDS and others have evaluated the incidence during a short period of time (from days to several weeks) and then extrapolated their data to estimates of a one-year incidence. Very few studies have collected information for an entire year, and none of them have evaluated the degree of hypoxemia under standard ventilatory settings, as it has been proposed recently by the HELP Network (Am J Respir Crit Care Med 2007; 176:795-804).
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiekontakt
- Navn: Yolanda M Lopez, Pediatrician
- Telefonnummer: 6312 0034946006000
- E-post: yolandamarg.lopezfernandez@osakidetza.net
Studer Kontakt Backup
- Navn: Amelia Martinez de Azagra, Pediatrician
- Telefonnummer: 0034915035929
- E-post: amartinez.hnjs@salud.madrid.org
Studiesteder
-
-
Vizcaya
-
Baracaldo, Vizcaya, Spania, 48903
- Rekruttering
- Cruces Hospital
-
Ta kontakt med:
- Yolanda M Lopez, Pediatrician
- Telefonnummer: 6312 0034946006000
- E-post: yolandamarg.lopezfernandez@osakidetza.net
-
Ta kontakt med:
- Amelia Martinez de Azagra, Pediatrician
- Telefonnummer: 0034915035929
- E-post: amartinez.hnjs@salud.madrid.org
-
Underetterforsker:
- Yolanda M Lopez, Pediatrician
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion criteria:
- All patients, age ranging from 1 month to 15 years old
- Must be able to meet the American European Consensus definition of ALI and ARDS(no indication of heart failure or a pulmonary capillary wedge pressure of greater than 18 mmHg, with pulmonary infiltrates in all four quadrants and a PaO2/FIO2 of > 200 to <300 mmHg (ALI) or ? 200 mmHg (ARDS).
Exclusion criteria:
- Younger than 1 month or older than 15 years old
- Cardiac disease
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
1. Incidence of Pediatric ALI, ARDS and non-ALI/ARDS in Spain based on the AECC and HELP criteria.
Tidsramme: One year
|
One year
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Risk factors and causes of ALI/ARDS
Tidsramme: One year
|
|
One year
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Kacmarec and Villar Robert and Jesus, Physicians, Spanish Intensive Care
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Acute lung injury in children
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Akutt lungesviktsyndrom
-
Wolfson Medical CenterUkjent
-
Chiesi Farmaceutici S.p.A.AvsluttetRespiratory Distress Syndrome (RDS)Forente stater
-
The First Affiliated Hospital with Nanjing Medical...UkjentRespiratory Distress Syndrome hos nyfødteKina
-
University of OuluFullførtRespiratory Distress Syndrome (RDS) hos nyfødteFinland
-
National University Health System, SingaporeFullførtAdult Respiratory Distress SyndromeSingapore
-
National Taiwan University HospitalFullført
-
University of Turin, ItalyRegione PiemonteFullførtAdult Respiratory Distress SyndromeItalia
-
King Abdullah International Medical Research CenterTilbaketrukketRespiratory Distress Syndrome (og [Hyaline Membrane Disease])Saudi-Arabia
-
University of BonnUkjentLungebetennelse | Sepsis | Adult Respiratory Distress SyndromeTyskland
-
M.D. Anderson Cancer CenterKatz FoundationFullførtAdult Respiratory Distress Syndrome | Blod- og margtransplantasjonForente stater